Neurological scales as endpoints in stroke studies. Aspects of statistical analysis;Neurologische skalen als endpunkte in schlaganfallstudien. Aspekte der statistischen auswertung

Nervenarzt

Volumn 71, Issue 10, 2000, Pages 797-801

  Bluhmki, E ^a   Windeler, J ^a   Hacke, W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Barthel Index; Ischaemic stroke; Modified Rankin Scale; National Institute of Health Scale; Thrombolysis

Indexed keywords

ARTICLE; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; HUMAN; RANKIN SCALE; SCORING SYSTEM; STATISTICAL ANALYSIS; STROKE;

CEREBRAL INFARCTION; CLINICAL TRIALS; DATA INTERPRETATION, STATISTICAL; FOLLOW-UP STUDIES; HUMANS; MATHEMATICAL COMPUTING; NEUROLOGIC EXAMINATION; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 0033788250     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050666     Document Type: Article

References (20)

1. Graphische verfahren zur statistischen analyse von neurologischen skalen in klinischen prufungen
2. Measurements of acute cerebral infarction. A clinical examination scale
3. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to S hours after symptom onset: The ATLANTIS study
4. Acute stroke therapy at the millennium: Consummating the marriage between the laboratory and bedside
5. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke; The European cooperative acute stroke study (ECASS)
6. Dichotomized efficacy endpoints and global endpoint analysis applied to the ECASS intention-to-treat data set
7. Randomised double-blind placebo controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
8. The appropriateness of the Wilcoxon test in ordinal data
9. Global tests for multiple binary outcomes
10. Calculation of power and sample size of bounded outcome scores
11. Functional evaluation; The Barthel Index
12. Tissue plasminogen activator for acute ischemic stroke
13. Procedures for comparing samples with multiple endpoints
14. Use of a global test for multiple outcomes in stroke trials with application to the NINDS rt-PA stroke trial
15. Interobserver agreement for the assessment of handicap in stroke patients